The background story on how the HPBCD became and orphan drug (Hommage’ a Families, Parents)
The Pulitzer Prize-winning Wall Street Journal science- and health writer, Amy Dockser Marcus, in her new book „We the Scientists”
A forum for researchers, students and applicants in the field of cyclodextrin technology
The Pulitzer Prize-winning Wall Street Journal science- and health writer, Amy Dockser Marcus, in her new book „We the Scientists”
The International conference on Orphan Drugs and Rare Diseases will be taking place during August 8-10, 2022 as a hybrid
On July 27, the Cyclo Therapeutics, a clinical stage biotechnology firm dedicated to developing life-changing medicines through science and innovation